Concepedia

Neelam Shah

NS

Statistics

Publications

3

Citations

869

H-Index

3

Active since

2004

Affiliations

AstraZeneca (United Kingdom)(Current)

Neelam Shah is an author at AstraZeneca (United Kingdom) specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

2004–2021

3

Publications

3

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Vincent A. Miller, Mark G. Kris, Neelam Shah et al. · Journal of Clinical Oncology · 2004 · 744 citations

Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy

R. Kim, Minsuk Kwon, Minae An et al. · Annals of Oncology · 2021 · 110 citations · Full text

, , +8

512O Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies

Rahul Aggarwal, Sarah E. Umetsu, Mallika Dhawan et al. · Annals of Oncology · 2021 · 15 citations

, , +8

1–3 of 3